Inactivating mutations in PTCH, SUFU, and GNAS or activating mutations of SMO, indicative of Hedgehog pathway misregulation, have been described for sporadic basal cell carcinoma and medulloblastoma tumors [92,93,94,95]. Here, SMO is linked to basal cell carcinoma.